Cargando…
Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663718/ https://www.ncbi.nlm.nih.gov/pubmed/26648869 http://dx.doi.org/10.3389/fphar.2015.00285 |
_version_ | 1782403343961817088 |
---|---|
author | Butelman, Eduardo R. Kreek, Mary Jeanne |
author_facet | Butelman, Eduardo R. Kreek, Mary Jeanne |
author_sort | Butelman, Eduardo R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4663718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-46637182015-12-08 Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders Butelman, Eduardo R. Kreek, Mary Jeanne Front Pharmacol Pharmacology Frontiers Media S.A. 2015-11-30 /pmc/articles/PMC4663718/ /pubmed/26648869 http://dx.doi.org/10.3389/fphar.2015.00285 Text en Copyright © 2015 Butelman and Kreek. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Butelman, Eduardo R. Kreek, Mary Jeanne Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders |
title | Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders |
title_full | Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders |
title_fullStr | Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders |
title_full_unstemmed | Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders |
title_short | Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders |
title_sort | corrigendum: salvinorin a, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663718/ https://www.ncbi.nlm.nih.gov/pubmed/26648869 http://dx.doi.org/10.3389/fphar.2015.00285 |
work_keys_str_mv | AT butelmaneduardor corrigendumsalvinorinaakappaopioidreceptoragonisthallucinogenpharmacologyandpotentialtemplatefornovelpharmacotherapeuticagentsinneuropsychiatricdisorders AT kreekmaryjeanne corrigendumsalvinorinaakappaopioidreceptoragonisthallucinogenpharmacologyandpotentialtemplatefornovelpharmacotherapeuticagentsinneuropsychiatricdisorders |